Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Verisign Inc.

Start price
Target price
Perf. (%)
€169.72
11.09.20
-
04.11.21
-1.60%
25.11.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
Very low/no dividend yield expected
Verisign Inc.

Start price
Target price
Perf. (%)
€169.72
11.09.20
-
04.11.21
-1.60%
25.11.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
Very low/no dividend yield expected
Verisign Inc.

Start price
Target price
Perf. (%)
€169.72
11.09.20
-
04.11.21
-1.60%
25.11.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
Very low/no dividend yield expected
Chevron Corp.

Start price
Target price
Perf. (%)
€65.63
11.09.20
€55.00
05.10.20
-7.02%
05.10.20

Chevron Corp.

Start price
Target price
Perf. (%)
€65.63
11.09.20
€55.00
05.10.20
-7.02%
05.10.20

Kelly Services Inc. A

Start price
Target price
Perf. (%)
€14.30
10.09.20
-
15.09.20
-2.10%
15.09.20

Risky Investment
News Corp. B

Start price
Target price
Perf. (%)
€12.60
10.09.20
-
04.11.21
18.25%
20.11.20

Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Few uniques
News Corp. B

Start price
Target price
Perf. (%)
€12.60
10.09.20
-
04.11.21
18.25%
20.11.20

Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Few uniques
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€4.22
09.09.20
€8.00
04.11.21
42.75%
05.11.21

Could be worthwhile Investment >10% per year
Tesla Inc

Start price
Target price
Perf. (%)
€99.58
09.09.20
-
01.10.20
27.08%
01.10.20

Tesla Inc

Start price
Target price
Perf. (%)
€99.58
09.09.20
-
01.10.20
27.08%
01.10.20

Moderna Inc.

Start price
Target price
Perf. (%)
€48.88
08.09.20
-
04.11.21
36.01%
11.11.20

Significant cyclical dependencies
Higher risks for its business
buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€47.63
08.09.20
-
19.09.20
-4.25%
19.09.20

Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
buy
Altimmune

Start price
Target price
Perf. (%)
€10.11
08.09.20
€12.00
04.11.21
-8.42%
05.11.21

Could be worthwhile Investment >10% per year
Fair valuation
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
08.09.20
€7.00
21.09.20
46.07%
21.09.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
buy
Inpixon

Start price
Target price
Perf. (%)
€67.13
07.09.20
-
21.09.20
-1.68%
21.09.20

Could be worthwhile Investment >10% per year
buy
Southwest Airlines Co.

Start price
Target price
Perf. (%)
€33.18
07.09.20
-
04.11.21
12.57%
14.11.20

Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
Higher risks for its business
Wells Fargo & Co.

Start price
Target price
Perf. (%)
€20.50
07.09.20
€18.00
07.09.20
1.46%
07.09.20

Risky Investment
Kelly Services Inc. A

Start price
Target price
Perf. (%)
€15.30
07.09.20
-
10.09.20
-6.54%
10.09.20

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.94
06.09.20
-
19.09.20
49.80%
19.09.20

High risks for its business
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.63
06.09.20
€4.38
04.11.21
144.86%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
High Investments for future growth
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.63
06.09.20
€4.38
04.11.21
144.86%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
High Investments for future growth
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.63
06.09.20
€4.38
04.11.21
144.86%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
High Investments for future growth
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€128.00
06.09.20
€125.00
04.11.21
-3.25%
06.11.20

Future proof or reliable business model
Higher risks for its business
Risky Investment
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€11.94
06.09.20
€24.00
28.09.20
7.41%
28.09.20

Could be very worthwhile Investment >20% year
Fair valuation
Increased challenges to pay loans and raise capital
Risky balance sheet